The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma

BACKGROUND: Outcomes for patients with metastatic renal cell carcinoma (mRCC) and tumour thrombus remain poor. Recent data suggest limited role for cytoreductive nephrectomy (CN) and data on thrombus response to systemic therapy (ST) is scarce. Here, we describe response and survival of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Abhenil, Al-Ezzi, Esmail, Li, Xuan, Moloney, Brian, Wilson, Brooke, Spiliopoulou, Pavlina, Sridhar, Srikala, Fallah-Rad, Nazanin, Chung, Peter, Hamilton, Robert James, O’malley, Martin, Hansen, Aaron R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147707/
https://www.ncbi.nlm.nih.gov/pubmed/36859686
http://dx.doi.org/10.1038/s41416-023-02166-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147707/
https://www.ncbi.nlm.nih.gov/pubmed/36859686
http://dx.doi.org/10.1038/s41416-023-02166-5

Ejemplares similares